Search filters

List of works by Hervé Avet-Loiseau

A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets

scientific article published on 27 November 2013

ABT-737 is highly effective against molecular subgroups of multiple myeloma

scientific article

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

scientific article published on 28 September 2007

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis ⬇️

scientific article

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.

scientific article

CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis

scientific article published on 4 September 2007

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

scientific article published on 24 June 2013

Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients

scientific article

Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles

scientific article

Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-r

scientific article

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

scientific article published on 03 February 2011

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

scientific article published on 03 February 2011

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

scientific article published on 03 February 2011

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies

scientific article published on 11 April 2011

Differential and limited expression of mutant alleles in multiple myeloma

scientific article

European perspective on multiple myeloma treatment strategies: update following recent congresses

scientific article

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

scientific article published on 17 November 2017

Frequent engagement of RelB activation is critical for cell survival in multiple myeloma

scientific article

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du

scientific article published on 14 July 2014

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

scientific article

Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients

scientific article published on 26 July 2011

Genomics in multiple myeloma

scientific article published on March 2011

Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

scientific article published on 22 April 2015

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

scientific article published on January 2014

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

scientific article

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

scientific article published on August 2016

International staging system for multiple myeloma

scientific article

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

scientific article published on 15 May 2015

Logic programming reveals alteration of key transcription factors in multiple myeloma

scientific article

Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma

scientific article

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

scientific article

Minimal Residual Disease by Next-Generation Sequencing: Pros and Cons

scientific article

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

scientific article

NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML

scientific article

Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma

scientific article published on 17 March 2015

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results

scientific article published on 9 January 2015

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.

scientific article

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

scientific article published on 03 October 2018

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System ⬇️

scientific article

Prognostic significance of copy-number alterations in multiple myeloma

scientific article

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

scientific article

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

scientific article published on 3 August 2015

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience

scientific article

Role of genetics in prognostication in myeloma

scientific article published on December 2007

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

scientific article published on 11 October 2016

Significant biological role of sp1 transactivation in multiple myeloma

scientific article

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

scientific article

Stem-cell transplantation in multiple myeloma

scientific article

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

scientific article

The role of complete response in multiple myeloma

scientific article published on 28 July 2009

The shaping and functional consequences of the dosage effect landscape in multiple myeloma ⬇️

scientific article

The translocation t(4;14) can be present only in minor subclones in multiple myeloma

scientific article published on 15 July 2013

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

scientific article published on 21 March 2016

Treatment of relapsed and refractory multiple myeloma in the era of novel agents

scientific article published on 21 September 2010

Ultra high-risk myeloma

scientific article published on January 2010

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

scientific article

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

scientific article

Paulina is supported by:

About Paulina

Help